Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Thomas J Moss"'
Autor:
Thomas J. Moss
Publikováno v:
BONE MARROW PROCESSING and PURGING ISBN: 9781003068501
BONE MARROW PROCESSING and PURGING
BONE MARROW PROCESSING and PURGING
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::137e00d39fb26422428c2d85af7bdab3
https://doi.org/10.1201/9781003068501-13
https://doi.org/10.1201/9781003068501-13
Autor:
Marc Klapholz, Pamela Hyde, Timothy D. Henry, Ahmed Abdel-Latif, Douglas W. Losordo, Dean J. Kereiakes, Vitaly Druker, David M. Shavelle, Charles J. Davidson, Gregory W. Barsness, David J. Mazzo, Thomas J. Moss, Candice Junge, Catalin Toma, Andrew L. Pecora, Arshed A. Quyyumi, Robert A. Preti, Stephen Frohwein, Nabil Dib, Richard A. Schatz, Robin L. Smith, Martin Cohen, Alejandro Vasquez, Anna Maria Kanakaraj, Gary L. Schaer, Amy S. Chung, Joseph Poole
Publikováno v:
Circulation Research. 120:324-331
Rationale: Despite direct immediate intervention and therapy, ST-segment–elevation myocardial infarction (STEMI) victims remain at risk for infarct expansion, heart failure, reinfarction, repeat revascularization, and death. Objective: To evaluate
Autor:
Arshed Quyyumi, Dean J Kereiakes, David M Shavelle, Timothy D Henry, Ahmed Abdel-Latif, Catalin Toma, Gregory Barsness, Steve C Frohwein, Richartd A Schatz, Martin Cohen, Charles Davidson, Nabil Dib, Marc Klapholz, Gary L Schaer, Alejandro Vasquez, Thomas J Moss, AnnaMaria Kanakaraj, Vitaly Druker, Ken Harper, Amy Chung, Candice Junge, Robert Preti, Robin Smith, David J Mazzo, Andrew Pecora, Douglas W Losordo
Publikováno v:
Circulation. 132
Background: Prior studies suggest an association between naturally high circulating levels of CD34+ cells (CD34) and better outcomes following ischemic events. Pts in the treatment arm of the PreSERVE-AMI study were infused with all CD34 yielded from
Autor:
Edward A Copelan, John Glassco, Susan Cantwell, Thomas J. Moss, Andrew L. Pecora, Douglas Kahn, Jan Jansen, Brenda W Cooper, Roger H Herzig, Amy A. Ross, Marina Prilutskaya, Andrew Jennis, Luke P. Akard, Stuart L. Goldberg, M.John Kennedy, Robert A. Preti, Hillard M Lazarus, Scott D. Rowley, Richard Meagher
Publikováno v:
Biology of Blood and Marrow Transplantation. 8(10):536-543
The incidence and clinical relevance of tumor cells contaminating the stem cell products of patients with advanced breast cancer treated with high-dose chemotherapy is uncertain because prior studies used small sample sizes and lacked standardization
Autor:
Michael Griffith, Bonnie Mills, Ninh H. Nguyen, Marina Prilutskaya, Julie Burgess, Andrew Schaeffer, Tehila Umiel, Thomas J. Moss
Publikováno v:
Journal of Hematotherapy & Stem Cell Research. 9:895-904
Contaminating tumor cells in peripheral blood stem cell (PBSC) grafts infused for hematopoietic rescue after high-dose chemotherapy could potentially contribute to relapse in BrCa patients. To date the prevalence of PBSC contamination in BrCa patient
Autor:
Thomas J. Moss
Publikováno v:
Cancer and Metastasis Reviews. 18:91-100
With the advent of new therapeutic modalities, the treatment options for oncologists can vary greatly depending upon the aggressiveness of the patient's cancer. Patients may receive no therapy, adjuvant therapy, aggressive adjuvant therapy (taxane ba
Autor:
Thomas J. Moss
Publikováno v:
Cancer Control. 5:406-414
Background Despite the initial success of high-dose therapy and bone marrow transplant, the major reason for posttransplant failure is relapse of disease. Reinfusion of tumor cells may contribute to relapse in autologous stem cell transplants. We now
Autor:
Klaus Pantel, Thomas J. Moss
Publikováno v:
Journal of Hematotherapy. 5:511-517
This conference was held on June 23–25, 1996, at the Kunstlerhaus, Munich, Germany, and was sponsored by the International Society for Hematotherapy and Graft Engineering, as well as AMGEN...
Autor:
Thomas J. Moss
Publikováno v:
ImmunoMethods. 5:226-231
There is increasing evidence that the presence of tumor cells within autologous hematopoietic cell grafts may increase the risk of relapse of disease post-transplant. The sensitive detection of minimal residual disease is therefore central to improvi
Autor:
Mitchell Cairo, Bruce Bostrom, Carole G. Hurvitz, Victor M. Santana, Joel Weinthal, Thomas J. Moss
Publikováno v:
Blood. 83:3085-3089
Peripheral blood stem cells (PBSCs) are being used as an alternative to autologous marrow rescue for hematopoietic reconstitution after high- dose chemotherapy in patients with neuroblastoma and other solid malignancies. Use of PBSCs is preferred by